期刊文献+

细胞周期抑制蛋白p21^(cipl)在狼疮肾炎肾组织中的表达及其意义 被引量:5

Expression of cell cyclin inhibition protein p^(21cipl) in renal tissue of lupus nephritis and its significance
原文传递
导出
摘要 目的 了解狼疮肾炎(LN)中细胞周期抑制蛋白p21^(cipl)的表达并探讨其与肾脏病病理改变、细胞增生及LN肾组织活动性的关系。方法 采用微波免疫组织化学染色法检测LN肾组织p21^(cipl)表达,并进一步分析其与肾小球增殖细胞核抗原(PCNA)阳性细胞数、LN活动指数、细胞增生等肾脏病理改变的相关关系。结果 正常肾小球细胞无或仅有较弱 p21^(cipl)。表达.LN肾小球细胞p21^(cipl)的表达显著上调,尤以非Ⅳ型为显著。LN肾组织p21^(cipl)阳性细胞数、PCNA阳性细胞数及LN肾组织活动指数显著负相关。结论 p21^(cipl)在 LN肾小球细胞中呈高表达,且与肾小球细胞增生程度密切相关p21^(cipl)可能参与LN发病的过程。 Objective To investigate the role of p^(21cipl) in the pathogenesis of lupus nephritis (LN), cell proliferation and its correlation with activity of LN. Methods Microwave-based immunohistochemistry was used to detect the expression of p^(21cipl) and PCNA in renal tissue of LN and normal control. At the same time , the correlation between expression of p^(21cipl) and renal injuries in LN was examined. Results p^(21cipl) was absent in the normal glomeruli. The expression of p^(21cipl) was significantly higher in LN than that in normal control. specially in non-type IV LN. The number of p^(21cipl) positive cells in renal tissue of LN showed a significantly negative correlation with PCNA protein expression and kidney tissue activity of LN. Conclusion Increased expression of p^(21cipl) in renal tissue of LN has a strong correlation with glomerular cell proliferation and may participate in the pathogenesis of lupus nephritis.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2002年第1期17-20,共4页 Chinese Journal of Nephrology
基金 中山医科大学科研启动基金(98027)
关键词 狼疮肾炎 细胞周期抑制蛋白 P21^CIP1 增殖细胞核抗原 Lupus nephritis Cell cyclin inhibition protein p^(21cipl) Proliferating cell nuclear antigen
  • 相关文献

参考文献8

  • 1Stuart JS. Cell-cyclin control and renal disease. Kidney Int, 1997,52: 294-308.
  • 2Toyochima H, Hatter T. p27, a novel inhibition of G1 cyclin-CDK protein kinase activity , is related to p21. Cell, 1994, 78: 67-74.
  • 3Conraol LP. Evaluation of kidney biopsy specimens. In: Tisher CC, Brenner BM, eds. Renal pathology. Philadelphia: J B Lippincott Company, 1994. 85-115.
  • 4Luo Y, Hurwite J, Massague. Cell-cyclin inhibition by independent CDK and PCNA binding domains in p21cipl. Nature, 1995, 375:159-161.
  • 5Wag A S, Hannon GJ, Beach D, et al. The p21cipl inhibitor ofcyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 1994, 369: 574-578.
  • 6Takemara T, Okada M, Akano N, et al. Proto-oncogene expression in human glomerular disease. J Pathol, 1996, 178:343-351.
  • 7Yamamoto T, Noble NA, Cohen AH, et al. Expression of transforming growth factor-beta isoforms in human glomerular disease. Kidney Int 1996,49: 461-469.
  • 8Shankland SJ, Huso C, Coats SR, et al. Change in cell-cyclin protein expression during experimental mesangial proliferative glomerulonephritis. Kindey Int, 1996,50: 1230-1239.

同被引文献45

  • 1周滨,张奉春,董怡.补体C1q及抗C1q抗体与系统性红斑狼疮及狼疮肾炎相关性的研究[J].中华风湿病学杂志,2005,9(12):725-728. 被引量:23
  • 2Marcus RG, England R, Nguyen K, et al. Altered renal expression of the insulin-responsive glucose transporter GLUT 4 in experimental diabetes mellitus. AmJ Physiol, 1994,270: F816-F824.
  • 3UKPDS group study. Intensive blood-glucose control with sulphonylureas, or insulin compared with conventional treatment and risk or complication in patient with type 2 diabetes (UKPDS 33) .Lancet, 1998, 352: 837.
  • 4Cary W, Kitt FP. Impaired glucose transporter as a cause of decreased insulin stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med, 1999, 341: 240-246.
  • 5Bonadonua RC, Delprato S. Roles of glucose transporter and glucose phosphylation in muscle insulin resistance of NIDDM. Diabetes,1996,45: 915-925.
  • 6Al-Awqati Q, Preising PA. Size does matter: will knockout of P21WAF1/cipl save the kidney by limiting compensatory renal growth.Proc Natl Acad Sci USA, 1999,96: 10551.
  • 7Al-Douahji M, Brugarolas J, Brown PA, et al. The cyclin kinase inhibitot P21WAD1/cipl is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int, 1999, 56 Suppl: 1661-1699.
  • 8Shepherd PR, Kahn BB. Glucose transporters and insulin action for insulin resistance and diabetes mellitus. New Engl J Med, 1999,341: 248-257.
  • 9Shankland SJ. Cell cycle control and renal disease. Kidney Int,1997, 52: 294-308.
  • 10Sugiyama A, Nagaki M, Moriwaki H, et al. Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor-β. Biochem Physiol, 1997, 238: 539-543.

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部